95070 ⎘
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
Sub-classes:RECOMBINANT POLYPEPTIDES WITH BERBERINE BRIDGE ENZYME ACTIVITY USEFUL FOR THE BIOSYNTHESIS OF CANNABINOIDS
#2EXTRACTION OF CANNABINOIDS FROM WET BIOMASS
#3Methods of preparing synthetic cannabichromene and cannabicitran and derivatives thereof
#4Therapeutics for the treatment of glaucoma
#5Synthetic Antibacterial Compounds and Uses Thereof
#6VITAMIN E DERIVATIVES AND THEIR USE AS MULTI-SCALE IMAGING AGENTS
#7Compounds and methods for inhibiting CPY26 enzymes
#8Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents
#9Therapeutics for the treatment of glaucoma
#10NOVEL USE OF SUBSTITUTED CHROMAN-6-OLS
#11Compounds and methods for inhibiting CYP26 enzymes
#12Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents
#134-sulfur pentafluoride phenol compound and preparation method therefor, and preparation method for sulfur pentafluoride substituted benzopyran compound
#14Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors
#15Modulators of cystic fibrosis transmembrane conductance regulator protein
#16Therapeutics for the treatment of glaucoma
#17N-substituted benzamides and methods of use thereof
#18METHOD FOR PRODUCING HETEROCYCLIC COMPOUND
#19Pro-drug compounds
#20Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A
#21Potassium channel blockers
#22Fluorinated estrogen receptor modulators and uses thereof
#23Estrogen receptor modulators and uses thereof
#24Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders
#25Tocotrienol derivatives and associated methods
#26Potassium channel blockers
#27Process for the cyclodehydration of diols and use thereof for the manufacturing of ambrafuran and other cycloether derivatives
#28N-substituted benzamides and methods of use thereof
#29N-substituted benzamides and methods of use thereof
#30Anti-leishmanial compound and anti-leishmanial drug
#31Tocotrienol derivatives and associated methods
#32TRPV1 antagonists
#33Neuroprotective compositions and methods
#34Chroman derivatives
#35Peptidic compounds
#36Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
#37Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
#38Potassium channel blockers
#39Chroman derivatives
#407,8-bicycloakyl-chroman derivatives
#41Human adam-10 inhibitors
#42Benzopyran derivatives having inhibitory activities against liver fibrosis and cirrhosis and their pharmaceutical uses
#43Peptidic compounds
#44Benzopyran derivatives as potassium channel openers
#45Diamine derivative, production process therefor and antioxidant
#46Chroman derivatives as lipoxygenase inhibitors
#47Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
#48Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
#49Human ADAM-10 inhibitors
#506-alkylamino-2,2′-disubstituted-7,8-disubstituted-2H-1-benzopyran derivatives as 5-lipoxygenase inhibitor
#51Process for producing aminobenzopyran compound
#52Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
#53Chroman derivatives
#547,8-bicycloalkyl-chroman derivatives
#55Treatment of mitochondrial diseases
#56Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis